Cromos Pharma highlights Sarcoma Awareness Month
This July, Cromos Pharma is highlighting Sarcoma Awareness Month. What are sarcomas? Sarcomas are rare malignant (cancer) tumors that start in the bones and soft tissues. The most common type of sarcoma is soft tissue sarcoma. Four out of five sarcomas occur in soft issues. Over half of these are found in the leg but
Cromos Pharma on best practice for a well-designed clinical study protocol
A good clinical study protocol is the foundation for a successful clinical trial. More than simply an instruction manual, the protocol serves many purposes and is the core mechanism used to translate an idea into a clinical trial. When writing a protocol it is important to carefully consider the research questions, its clinical importance and interrogate
Watch Cromos Pharma explain the benefits of locating your clinical trial in Central and Eastern Europe
Why are Central and Eastern Europe the hottest locations for clinical trials? Cromos Pharma’s CEO Vlad Bogin, MD, FACP answers this question in a keynote given at OCT Eastern Europe this week (June 15, 2021). Watch the video here: Learn about the key benefits on offer to international sponsors conducting trials in these locations: Large treatment-naïve
